In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study

Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition

(2018) Buranee Kanchanatawan et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs

(2018) Buranee Kanchanatawan et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Associations between severity of anxiety and clinical and biological features of major affective disorders

(2018) Fernanda Liboni Cavicchioli et al.   PSYCHIATRY RESEARCH

Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway

(2017) Buranee Kanchanatawan et al.   METABOLIC BRAIN DISEASE

Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia

(2017) Buranee Kanchanatawan et al.   MOLECULAR NEUROBIOLOGY

Secondary negative symptoms — A review of mechanisms, assessment and treatment

(2017) Matthias Kirschner et al.   SCHIZOPHRENIA RESEARCH

The enduring effects of depressive thoughts on working memory

(2016) Nicholas A. Hubbard et al.   JOURNAL OF AFFECTIVE DISORDERS

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

(2016) Justin Davis et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome

(2015) Karin A. M. Janssens et al.   PSYCHOSOMATIC MEDICINE

Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables

(2015) Miao Yu et al.   PLoS One

Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue

(2014) Jie Li et al.   PSYCHO-ONCOLOGY

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression

(2012) Michael Maes et al.   METABOLIC BRAIN DISEASE

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

(2012) George Anderson et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression

(2012) George Anderson et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Inflammatory and Cell-Mediated Immune Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression: Inflammatory Markers Are Higher in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome than in Depression

(2012) Michael Maes et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Episodic memory and impairment of an early encoding process in schizophrenia.

(2010) Marie-Laure Grillon et al.   NEUROPSYCHOLOGY

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways

(2010) Michael Maes   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY